<p><b>TABLE OF INTERACTIONS WITH</b></p>

<p><b>VEMURAFENIB</b></p>

<p><b>From the French ANSM drug interactions document of </b></p>

<p><b>September 2016, pp. 225-226</b></p>

<table cellspacing="0" cellpadding="0" border="1">
<tbody>
<tr>
<td valign="top"><p><b>VEMURAFENIB</b></p>

<p><b>RxNorm: 1147220</b></p>

<p><b>ATC: L01XE15</b></p></td>
<td valign="top"><p><b>BUPROPION</b></p>

<p><b>RxNorm: 42347</b></p>

<p><b>ACT: N06AX12</b></p></td>
<td valign="top"><p>Risk of decrease of the concentrations of the bupropion, with increase of its active metabolite and increased toxicity</p></td>
<td valign="top"><p><b>Take into account</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>VEMURAFENIB</b></p>

<p><b>RxNorm: 1147220</b></p>

<p><b>ATC: L01XE15</b></p></td>
<td valign="top"><p><b>COMBINED ESTROGEN-PROGESTIN CONTRACEPTIVES</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>G03AB-001</b></p></td>
<td valign="top"><p>Risk of decrease of the concentrations of the combined estrogen-progestin contraceptive with the consequence of a risk of ineffectiveness</p></td>
<td valign="top"><p><b>Not recommended</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>VEMURAFENIB</b></p>

<p><b>RxNorm: 1147220</b></p>

<p><b>ATC: L01XE15</b></p></td>
<td valign="top"><p><b>IFOSFAMIDE</b></p>

<p><b>RxNorm: 5657</b></p>

<p><b>ATC: L01AA06</b></p></td>
<td valign="top"><p>Risk of decrease of the concentrations of the ifosfamide, with increase of its active metabolite and increased toxicity</p></td>
<td valign="top"><p><b>Take into account</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>VEMURAFENIB</b></p>

<p><b>RxNorm: 1147220</b></p>

<p><b>ATC: L01XE15</b></p></td>
<td valign="top"><p><b>IMMUNOSUPPRESSANTS</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>L04A</b></p></td>
<td valign="top"><p>Risk of decrease of the concentrations of the immunosuppressants, with the consequence of a risk of ineffectiveness</p></td>
<td valign="top"><p><b>Not recommended</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>VEMURAFENIB</b></p>

<p><b>RxNorm: 1147220</b></p>

<p><b>ATC: L01XE15</b></p></td>
<td valign="top"><p><b>ENZYME INDUCERS</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>N03-J05-001 </b></p></td>
<td valign="top"><p>Risk of decrease of the concentrations of the vemurafenib, with lower effectiveness</p></td>
<td valign="top"><p><b>Not recommended</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>VEMURAFENIB</b></p>

<p><b>RxNorm: 1147220</b></p>

<p><b>ATC: L01XE15</b></p></td>
<td valign="top"><p><b>THEOPHYLLINE </b></p>

<p><b>RxNorm: 10438</b></p>

<p><b>ATC: R03DA04</b></p></td>
<td valign="top"><p>Large increase of the concentrations of theophylline, with risks of increase of its undesirable effects</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring and adjustment of the dosage of the theophylline during the treatment with vemurafenib and after it is stopped<b>. </b></p></td>
</tr>

</tbody>
</table>

